,
your personalized virtual assistant to find clinical trials. Go head, 
John P. Perentesis, MD
Cincinnati Children's Hospital Medical CenterCincinnati, Ohio - 45229-3039 |
- CLINICAL TRIALS 5
- CONDITIONS15
- INTERVENTIONS17
- SINCE2001
N99-02: Melphalan and Buthionine Sulfoximine Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Children With Resistant or Recurrent Neuroblastoma
August 2001 - December 2009
Fenretinide LXS in Treating Patients With Recurrent Refractory or Persistent Neuroblastoma
December 2005 - June 2010
Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
October 2009 - October 2018
Iodine I 131 Metaiodobenzylguanidine Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell or Bone Marrow Transplant for Relapsed or Refractory Neuroblastoma
September 2005 - September 2010
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
June 2010 - January 2014
Congenital Abnormalities
Nausea
Vomiting
Neuroblastoma
Body Weight
Weight Loss
Thrombocytopenia
Hemangioma
Cachexia
Body Weight Changes
Hemangioendothelioma
Lymphangiectasis
Vascular Malformations
Lymphangioma
Lymphatic Abnormalities
Placebo
Melphalan
Laboratory Biomarker Analysis
Filgrastim
Pharmacological Study
Carboplatin
Radiation Therapy
Etoposide
Iobenguane I 131
Buthionine Sulfoximine
Peripheral Blood Stem Cell Infusion
Peripheral Blood Stem Cell Transplantation
Sirolimus
Ketoconazole
Fenretinide Lipid Matrix
Autologous Bone Marrow Transplantation
Cyproheptadine Hydrochloride
